A real correction
Femtech addresses a knowledge gap that has shaped women's care for too long.
Femtech · Published 27 April 2026
Why Nicole Junkermann Believes in Femtech
The positive, practical case for backing technology that takes women's health seriously, in the words of someone who has watched the field grow up.
Femtech is one of the rare areas where doing good and building something valuable point in exactly the same direction.
Ask Nicole Junkermann why femtech holds her attention, and the answer is refreshingly direct: because the need is real, the science is catching up, and the impact reaches half the population. As an entrepreneur and investor with a long-running interest in healthtech and biotech, Nicole Junkermann sees femtech not as a passing theme but as a correction, a chance to fix something that has been overlooked for a very long time.
The gap that femtech is built to close
For much of medical history, women's health was studied less, funded less and understood less. The result is a knowledge gap that still shapes everyday care, from how symptoms are recognised to how treatments are dosed. Nicole Junkermann believes femtech exists to close that gap, building the evidence, the tools and the attention that women's health has been missing. When a field starts from a place of neglect, even modest progress can change a great many lives, and that asymmetry is precisely what draws her in. She explores this further in her note on closing the women's health gap.
Why the timing is right
Belief without timing is just hope, and Nicole Junkermann is clear that femtech has reached a genuine inflection point. Sensors are smaller and more accurate. Artificial intelligence can finally make sense of messy, personal data. Awareness has grown, so women expect and demand better. And a generation of founders has decided that subjects once treated as awkward, from menstruation to menopause, deserve serious, well-designed products. When need, science and culture line up like this, the conditions for lasting progress are unusually good.
Nicole Junkermann invests across artificial intelligence, healthtech, biotech, fintech and deep technology, and she sees femtech sitting at the meeting point of several of those strengths. The same advances that power modern diagnostics and data science can be turned toward questions that affect women every day, which is part of why she finds the field so promising.
What a strong femtech company looks like
Belief, for Nicole Junkermann, is disciplined rather than starry-eyed. When she considers a femtech company, a few things matter most. There has to be a real clinical need rather than a manufactured one. There should be evidence behind the product, not just a pleasing interface. Privacy must be treated as a feature in its own right, because the information involved is deeply personal. And the team should design with women, listening closely, rather than for an abstract user imagined from a distance.
She is also drawn to founders who think long term. The best health products are not built in a sprint; they earn trust slowly and improve with care. Nicole Junkermann tends to back people early and stay with them as they grow, which suits a field where patience and rigour matter more than noise. You can read more about her approach in how Nicole Junkermann thinks about investing in healthcare.
Beyond fertility: a whole-life field
One misconception Nicole Junkermann is keen to retire is that femtech is only about fertility. It began there for understandable reasons, but the field now stretches across a whole life: adolescence, mental wellbeing, heart and bone health, chronic conditions, and the long-neglected territory of menopause and later life. Designing for that full span, with patience and without awkwardness, is where she sees the most meaningful opportunity, and the most good waiting to be done.
Trust is the real product
If there is a single reason Nicole Junkermann believes femtech can endure, it is that the field has, on the whole, taken trust seriously. Women share intimate details with these tools, and the companies that respect that, by being clear about what they collect, generous with control and plain in their language, are the ones that build genuine loyalty. Nicole Junkermann often says that in health, trust is the real product; the features simply make it visible.
That belief in trust also keeps her optimism grounded. She is not interested in technology that demands constant attention or treats data carelessly. The femtech she admires is calm, respectful and useful, the kind of tool that fits gently into a life and knows when to step back.
A field worth believing in
So why does Nicole Junkermann believe in femtech? Because it answers a real and longstanding need; because the science and the timing have finally aligned; because the impact reaches across a whole life and a whole population; and because, at its best, it is built on respect. For someone whose wider work centres on technology that helps people live healthier lives, femtech is not a side interest. It is a clear example of the principle she returns to again and again. For more, see the femtech founders Nicole Junkermann admires or the profile of Nicole Junkermann.
The timing is right
Better sensors, capable artificial intelligence and rising expectations have aligned.
Trust first
In health, respect for personal information is the real product.
Frequently asked questions
Why does Nicole Junkermann believe in femtech?
Nicole Junkermann believes femtech can correct decades of under-investment in women's health, turning better data and thoughtful design into care that finally fits women's lives.
What does Nicole Junkermann look for in a femtech company?
Nicole Junkermann looks for a real clinical need, evidence behind the product, respect for privacy and a team that designs with women rather than for an abstract user.
Is femtech only about fertility?
No. Nicole Junkermann sees femtech as spanning the whole of a woman's life, including menopause, heart and bone health, mental wellbeing and everyday preventive care.
Keep reading: the future of women's health technology, what Nicole Junkermann wishes more people knew about femtech, or browse the Wellbeing Tech section.